Current Infectious Endophthalmitis Rates After Intravitreal Injections of Anti-Vascular Endothelial Growth Factor Agents and Outcomes of Treatment.

Overview of attention for article published in Ophthalmic surgery, lasers & imaging retina, June 2015

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (74th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

policy: 1 policy source

twitter: 4 X users

Readers on

mendeley: 49 Mendeley

So far, Altmetric has seen 3 policy documents that reference this research output.

Anti–Vascular Endothelial Growth Factor Drugs for Retinal Conditions

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 07 Feb 2018

CADTH is an independent, not-for-profit organization responsible for providing health care decision-makers with objective evidence to help make informed decisions about the optimal use of health technologies.

Anti-Vascular Endothelial Growth Factor Drugs for the Treatment of Retinal Conditions: A Review of Safety

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 28 Feb 2017

Aflibercept - Clinical Report

Cited by Canadian Agency for Drugs and Technologies in Health (CADTH) on 16 Nov 2015

This page shows the most recent policy documents that mention this research output. Click here to find out how to access more activity.